![Karin Hannader](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Hannader
Keine laufenden Positionen mehr
Health Technology
Profil
Ms. Karin Hannader is a Director-Clinical Affairs at QuickCool AB. Ms. Hannader was previously employed as a Principal by Novo Nordisk A and a Principal by Active Biotech AB.
Ehemalige bekannte Positionen von Karin Hannader
| Unternehmen | Position | Ende |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
| ACTIVE BIOTECH AB | Corporate Officer/Principal | - |
QuickCool AB
 QuickCool AB Medical SpecialtiesHealth Technology Provides non-invasive brain cooling systems | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
QuickCool AB
QuickCool AB Medical SpecialtiesHealth Technology Provides non-invasive brain cooling systems | Health Technology |
